{"transactions":[{"id":2335883,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-15T00:00:52.000Z","date":"2022-03-06","kind":"grant","acquired":true,"shares":35885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of March 6, 2022, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":223310,"source":{"system":"sec-edgar","filing":"0001104659-22-033496","document":"tm228679-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465922033496/tm228679-1_4seq1.xml","form_type":"4"}},{"id":2477591,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-11T01:05:07.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":35885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of March 6, 2021, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":187425,"source":{"system":"sec-edgar","filing":"0001104659-21-148754","document":"tm2135032-9_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921148754/tm2135032-9_4.xml","form_type":"4"}},{"id":3211426,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-13T21:01:31.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option becomes vested and exercisable as to 25% of the number of shares on each of the first four anniversaries of the grant date until fully vested and exercisable on the fourth anniversary of the grant date."}],"balance_after":80000,"derivative":{"exercise_price":7.33,"exercise_date":"2020-03-09","expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-20-033203","document":"tm2012148d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920033203/tm2012148d1_4.xml","form_type":"4"}},{"id":3222958,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-06T21:10:22.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":35885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on March 6, 2020 under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":151540,"source":{"system":"sec-edgar","filing":"0001104659-20-030195","document":"tm2011847d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920030195/tm2011847d1_form4.xml","form_type":"4"}},{"id":3330544,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-27T12:01:42.000Z","date":"2019-12-24","kind":"purchase","acquired":true,"shares":3000,"price":3.88,"value":11640.0,"ownership":{"direct":true},"balance_after":115655,"source":{"system":"sec-edgar","filing":"0001104659-19-076291","document":"tm1927404-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465919076291/tm1927404-3_4.xml","form_type":"4"}},{"id":3604490,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-08T22:02:42.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":35885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on March 6, 2019 under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":112655,"source":{"system":"sec-edgar","filing":"0001144204-19-013081","document":"tv514173_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419013081/tv514173_form4.xml","form_type":"4"}},{"id":3983143,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-26T20:49:57.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":35885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on March 6, 2018 under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":76770,"source":{"system":"sec-edgar","filing":"0001144204-18-016910","document":"tv489540_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420418016910/tv489540_4.xml","form_type":"4"}},{"id":3987882,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-20T14:48:44.000Z","date":"2018-03-15","kind":"purchase","acquired":true,"shares":5000,"price":3.5994,"value":17997.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4/A is being filed to reflect that this transaction was an open market purchase of the Issuer's securities (on March 19, 2018 this transaction was incorrectly reported on Form 4 as an acquisition pursuant to Rule 16b-3(d))."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.59 to $3.60, inclusive. The reporting person undertakes to provide to Brainstorm Cell Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":40885,"source":{"system":"sec-edgar","filing":"0001144204-18-015759","document":"tv488976_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420418015759/tv488976_4a.xml","form_type":"4/A","original_submission_date":"2018-03-19"}},{"id":3990037,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-19T20:05:48.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":5000,"price":3.5994,"value":17997.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.59 to $3.60, inclusive. The reporting person undertakes to provide to Brainstorm Cell Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":40885,"source":{"system":"sec-edgar","filing":"0001144204-18-015580","document":"tv488647_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420418015580/tv488647_4.xml","form_type":"4"}},{"id":4400741,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-06T21:05:41.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":47847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option is fully vested and exercisable as of the date of grant and shall remain exercisable until the 2nd anniversary of the date of grant."}],"balance_after":47847,"derivative":{"exercise_price":4.18,"exercise_date":"2017-03-06","expiration_date":"2019-03-06","underlying":"Common Stock","underlying_shares":47847},"source":{"system":"sec-edgar","filing":"0001144204-17-012940","document":"v461202_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420417012940/v461202_4.xml","form_type":"4"}},{"id":4400740,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":129155,"kind":"person","name":"Kern Ralph Dr.","position":1,"cik":"0001699684","reported_name":"Kern Ralph Dr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-06T21:05:41.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":35885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on March 6, 2017 under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":35885,"source":{"system":"sec-edgar","filing":"0001144204-17-012940","document":"v461202_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420417012940/v461202_4.xml","form_type":"4"}}]}